Text Size

Study of Mindfulness-Based Cognitive Therapy (MBCT)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Sean Barnes, Binghamton University
ClinicalTrials.gov Identifier:
NCT00943033
First received: July 13, 2009
Last updated: September 19, 2012
Last verified: September 2012
History of Changes
  Purpose

Research aimed at assessing changes in depressogenic thinking and the ability to disengage from depressogenic thinking following Mindfulness-Based Cognitive Therapy


Condition Intervention
Major Depressive Disorder
 Behavioral: Mindfulness-Based Cognitive Therapy

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Toward Identifying the Mechanisms of Action in Mindfulness-Based Cognitive Therapy

Resource links provided by NLM:

MedlinePlus related topics: Depression
U.S. FDA Resources

Further study details as provided by Binghamton University:

Primary Outcome Measures:
  • Sustained Attention to Response Task [ Time Frame: zero to four weeks pre-treatment and zero to three weeks post-treatment ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Five Facet Mindfulness Questionnaire [ Time Frame: zero to four weeks pre-treatment and zero to three weeks post-treatment ] [ Designated as safety issue: No ]

Enrollment: 48
Study Start Date: August 2009
Study Completion Date: July 2010
Primary Completion Date: July 2010 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Mindfulness-Based Cognitive Therapy plus treatment as usual Behavioral: Mindfulness-Based Cognitive Therapy
Mindfulness-Based Cognitive Therapy for the prevention of depressive relapse/recurrence
No Intervention: MBCT Waitlist plus Treatment as Usual

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • History of two or more Major Depressive Episodes or history of a Major Depressive Episode lasting at least one year
  • Can speak, read, and understand English

Exclusion Criteria:

  • Meet Criteria for Current Major Depressive Episode or are in partial remission
  • BDI-II score above 19
  • Abuse alcohol or drugs
  • Current Dysthymic Disorder
  • History of: psychosis when not depressed or intoxicated, Mania, Hypomania, Obsessive Compulsive Disorder, Posttraumatic Stress Disorder, Anorexia Nervosa, Bulimia Nervosa
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00943033

Sponsors and Collaborators
Binghamton University
Investigators
Principal Investigator: Sean M. Barnes, MS Binghamton University SUNY
  More Information

No publications provided

Responsible Party: Sean Barnes, PhD, Binghamton University
ClinicalTrials.gov Identifier: NCT00943033     History of Changes
Other Study ID Numbers: MLI-FJVRF-08-SMB
Study First Received: July 13, 2009
Last Updated: September 19, 2012
Health Authority: United States: Institutional Review Board

Keywords provided by Binghamton University:
MBCT
Mindfulness-Based Cognitive Therapy
Mindfulness
Meditation
 Relapse Prevention
Recurrent Depression
Depression
Major Depressive Disorder

Additional relevant MeSH terms:
Depressive Disorder
Depression
Depressive Disorder, Major
 Mood Disorders
Mental Disorders
Behavioral Symptoms

ClinicalTrials.gov processed this record on May 16, 2013